The next board meeting for Beam Therapeutics Inc is on 06 Aug 2025 for the purpose of Beam Therapeutics Inc Second Quarter Earnings Results for 2025See details
Beam Therapeutics Inc has a share price target of US$ 44, revenue growth forecast of -12.8%, and profit growth estimate of -12.3% for FY25, based on top 17 analyst calls.